DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qwh2pd/global) has announced the addition of the "Global Parkinson's Disease Market Report, 2016 with GSK, Novartis, Orion & Teva Dominating" report to their offering.
One of the main drivers propelling the growth of the market is the steadily growing aging population worldwide. The increasing aging population is contributing to the growth of the market. The number of patients suffering from Parkinson's disease is increasing owing to the increasing aging population both in the developing and developed nations.
Vaccine development is undergoing significant advancements in the market; special focus is given to neurodegenerative diseases such as Parkinson's disease. As the drugs used to treat patients with Parkinson's have only been able to address the symptoms, a huge unmet need lies in this region. There isn't a single drug available that can modify the course of the disease. AFFiRiS AG, an Australian pharmaceutical company, is involved in the first-ever Phase I clinical development trial for Parkinson's disease (PD01A). The vaccine targets the protein alpha-Synuclein, which is responsible for the onset of the disease. PD01A is expected to encourage disease modifying effects and not symptomatic relief.
Further, the report states that one of the major challenges faced by the market is the weak pipeline landscape. Most products in the pipeline lack molecules which can potentially achieve blockbuster status in the near future.
The key vendors dominating this space include:
- GlaxoSmithKline plc
- Novartis AG
- Orion Corp.
- Teva Pharmaceuticals Industries Ltd.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
05. Scope of the Report
06. Market Landscape
07. Geographical Segmentation
08. Key Leading Countries
09. Rate of Incidence and Prevalence
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
For more information visit http://www.researchandmarkets.com/research/qwh2pd/global
